The University of Chicago Header Logo

Connection

Veeral Sheth to Pyrimidines

Back to Details
This is a "connection" page, showing publications Veeral Sheth has written about Pyrimidines.
Veeral Sheth
Connection Strength
0.043
Pyrimidines
  1. A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2022 07; 239:180-189.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.